Our corporate investigations coverage identifies companies and industries that may be impacted by new or existing laws and regulations. For individual companies, we report on specific business practices that may pose legal or regulatory risks. Our industry-focused content examines new regulations that may materially affect an entire industry, as well as identifying the companies within the industry likely to be most impacted. Our journalists understand the impact regulatory agency actions can have on financial markets and provide insights on the potential results of regulatory actions, whether they include fines or material changes to a company’s business or an industry’s operation.
PDF
CONTACT US
A proposed rule from the Center for Medicare and Medicaid Services (CMS) would disincentivize hospital ownership of outpatient imaging clinics—potentially driving down costs for patients and the government—and may push more services out of the hospital setting into ambulatory surgical...
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • HHS OIG may seek to update anti-kickback regulations to accommodate DTC drug...
The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...
The information contained in this report is compiled from the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. The MAUDE database contains reports of deaths, injuries, and malfunctions relating to the use of medical devices and is updated monthly with reports...
Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: • Vought to testify on Capitol Hill next week. • CFPB reverses course and...
The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week include: • Virginia suspends Harrow’s compounding licenses. • CMS walks back pricing...
The TMT Weekly is a forward-looking tipsheet that covers tech policy across The Capitol Forum’s U.S. policy coverage universe, from Congress to the Courts. If you have any feedback, feel free to email...
A new letter to the European Commission, obtained by The Capitol Forum, highlights the alleged anticompetitive effects of SAP’s (SAP) updated application programming interface (API) policy and calls on the Commission to open an investigation into the...
Financials Friday is a weekly overview of financial news and analysis of the timing and priorities of key agencies including the Federal Reserve, OCC and FDIC. Key stories we’re following this week include: SEC Chair says crypto bank deposits to be approved by next year. New Illinois...
The Capitol Forum’s corporate investigations team has demonstrated a consistent track record of successfully identifying companies that have legal, regulatory, or business risk.
DOWNLOAD PDF
Partner and Antitrust Chair, Fried Frank
"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."
Founding Partner, Geradin Partners; Professor of Competition Law and Economics, Tilburg University
“The Capitol Forum’s European coverage stands out for its depth, accuracy, and timeliness. Their investigative reporting and analysis on antitrust, corporate conduct, and regulatory developments offer valuable insights for practitioners and academics alike. As someone deeply engaged in European competition law, I’ve found their work to be consistently thoughtful and impactful.”
Partner, Willkie Farr & Gallagher
"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."
Partner, Fenwick & West
"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."
